Top and Current
Source: (remove) : Joel Beatty
RSSJSONXMLCSV
Top and Current
Source: (remove) : Joel Beatty
RSSJSONXMLCSV
Fri, August 2, 2024
Mon, July 29, 2024
Thu, July 25, 2024
Fri, May 17, 2024
Thu, May 9, 2024
Tue, May 7, 2024
Thu, April 11, 2024
Tue, March 19, 2024
Tue, March 12, 2024
Mon, March 11, 2024
Fri, March 1, 2024
Tue, January 30, 2024
Wed, January 3, 2024
Tue, October 3, 2023
Fri, June 30, 2023
Tue, May 2, 2023
Thu, April 27, 2023
Tue, February 7, 2023
Thu, November 10, 2022
Fri, July 29, 2022
Wed, May 11, 2022
Thu, March 3, 2022
Tue, December 21, 2021
Thu, September 9, 2021
Tue, August 10, 2021
Thu, June 17, 2021
Tue, June 8, 2021
Fri, February 12, 2021
Thu, January 14, 2021
Tue, January 12, 2021
Mon, December 21, 2020
Thu, October 29, 2020
Tue, September 15, 2020
Tue, September 8, 2020
Tue, June 9, 2020
Wed, April 1, 2020
Thu, March 26, 2020
Thu, March 12, 2020
Tue, February 18, 2020
Mon, December 9, 2019
Mon, November 25, 2019
Mon, November 18, 2019
Thu, October 24, 2019
Thu, October 3, 2019
Fri, September 27, 2019
Thu, August 1, 2019
Fri, July 19, 2019
Thu, May 16, 2019
Fri, March 1, 2019
Fri, December 7, 2018
Tue, November 6, 2018
Fri, November 2, 2018
Wed, October 17, 2018
Tue, October 16, 2018
Thu, October 11, 2018
Tue, September 25, 2018
Wed, May 23, 2018
Wed, October 19, 2016
Mon, November 10, 2014
Mon, May 12, 2014
Tue, April 22, 2014
Mon, January 6, 2014
Fri, November 8, 2013
Fri, October 18, 2013
Tue, August 27, 2013
Mon, March 4, 2013
Tue, November 27, 2012
Mon, April 30, 2012

Joel Beatty Maintained (BPMC) at Buy with Increased Target to $127 on, Aug 2nd, 2024


Published on 2024-10-28 13:08:15 - WOPRAI, Joel Beatty
  Print publication without navigation


Joel Beatty of Baird, Maintained "Blueprint Medicines Corporation" (BPMC) at Buy with Increased Target from $112 to $127 on, Aug 2nd, 2024.

Joel has made no other calls on BPMC in the last 4 months.



There are 13 other peers that have a rating on BPMC. Out of the 13 peers that are also analyzing BPMC, 4 agree with Joel's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Peter Lawson of "Barclays" Maintained at Hold with Increased Target to $105 on, Monday, July 29th, 2024
  • Michael Ulz of "Morgan Stanley" Maintained at Hold with Increased Target to $115 on, Friday, July 12th, 2024
  • Andrew Berens of "Leerink Partners" Upgraded from Sell to Hold and Increased Target to $97 on, Monday, May 6th, 2024
  • Christopher Raymond of "Piper Sandler" Maintained at Hold with Increased Target to $104 on, Friday, May 3rd, 2024


These are the ratings of the 9 analyists that currently disagree with Joel


  • Ami Fadia of "Needham" Reiterated at Strong Buy and Held Target at $130 on, Thursday, August 1st, 2024
  • Matthew Biegler of "Oppenheimer" Maintained at Buy with Increased Target to $125 on, Monday, July 8th, 2024
  • Reni Benjamin of "JMP Securities" Reiterated at Buy and Held Target at $125 on, Friday, June 7th, 2024
  • Sudan Loganathan of "Stephens & Co." Initiated at Buy and Held Target at $140 on, Tuesday, May 14th, 2024
  • Terence Flynn of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $168 on, Monday, May 6th, 2024
  • Andrew Fein of "HC Wainwright & Co." Maintained at Strong Buy with Increased Target to $135 on, Friday, May 3rd, 2024
  • David Lebowitz of "Citigroup" Maintained at Strong Sell with Increased Target to $76 on, Friday, May 3rd, 2024
  • David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $110 on, Friday, April 26th, 2024
  • Bradley Canino of "Stifel" Maintained at Strong Buy with Increased Target to $130 on, Friday, April 26th, 2024